Impact on estrogen receptor binding and target tissue uptake of [18F]fluorine substitution at the 16α-position of fulvestrant (faslodex; ICI 182,780)

This publication has 31 references indexed in Scilit:

• Update on the current use of hormonals as therapy in advanced breast cancer
  Anti-Cancer Drugs, 2003
• Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents
  Journal of Medicinal Chemistry, 2003
• Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 1. Receptor Interactions
  Journal of Medicinal Chemistry, 2003
• Synthesis of 2, 16α‐ and 4, 16α‐[16α‐¹⁸F]difluoroestradiols and their 11β‐methoxy derivatives for estrogen receptor imaging
  Journal of Labelled Compounds and Radiopharmaceuticals, 2001
• The use of 3-methoxymethyl-16β, 17β-epiestriol-O-cyclic sulfone as the precursor in the synthesis of F-18 16α-fluoroestradiol
  Nuclear Medicine and Biology, 1996
• The pure antiestrogen ICI 182,780 binds to a high‐affinity site distinct from the estrogen receptor
  International Journal of Cancer, 1995
• Anti‐proliferative and anti‐estrogenic effects of ICI 164,384 and ICI 182,780 in 4‐OH‐tamoxifen‐resistant human breast‐cancer cells
  International Journal of Cancer, 1994
• In vivo evaluation of 7α-[11-(4-[125I]Iodophenoxy)undecyl]-17β-estradiol: A potential vector for therapy of adrenal and estrogen receptor-positive cancers
  The Journal of Steroid Biochemistry and Molecular Biology, 1990
• Synthesis and structure-affinity of a series of 7.alpha.-undecylestradiol derivatives: a potential vector for therapy and imaging of estrogen-receptor-positive cancers
  Journal of Medicinal Chemistry, 1990
• Synthesis of 16-fluoroestrogens by unusually facile fluoride ion displacement reactions: prospects for the preparation of fluorine-18 labeled estrogens
  The Journal of Organic Chemistry, 1984